Dr Olivier Collignon works as Statistics Leader at GSK in the United Kingdom where he contributes to the development of clinical trials for immune-inflammatory diseases. He holds a PhD in Applied Mathematics and is especially interested in adaptive designs, basket/umbrella trials and historical controls and their applications to oncology. His expertise also consists in developing variable selection methods to detect promising biomarkers and build efficient clinical prediction models.

He previously worked as biostatistician in France and Luxembourg for 13 years. During this mission at the Luxembourg Institute of Health he was seconded at the European Medicines Agency in London for 4 years, where he gained regulatory experience and participated to the scientific evaluation of the design and results of clinical trials to obtain marketing authorization of new drugs in Europe.